 |
Letzte Umfrage
|
|
Welches Angebot von migraeneinformation.de schätzen Sie besonders?
|
| Forum | |  | 84,9% | | News | | | 83,6% | | Umfragen | | | 27,4% | | Termine | | | 19,2% | | Links | | | 11,0% | | Infos zu Medikam. | | | 26,0% | | Infos zu Ernährung | | | 71,2% | | Infos zu Therapien | | | 27,4% | | Online-Tests | | | 43,8% | | Migräne-Kalender | | | 20,5% | |
|
|
Fallstudie: Herzinfarkt nach Einnahme von Ascoptop [Pharma]
10 Feb 06
 |
Patient hatte keine auffälligen kardiovaskulären Risiken |
Die Studie berichtet von einem Patienten, der keine schwerwiegende Herzerkrankung aufwies, trotzdem unmittelbar nach Einnahme von Ascotop gegen Migräne einen Herzinfarkt erlitt.
Abstract:
Myocardial infarction after taking zolmitriptan.
We report the case of a patient with mild non-obstructive coronary artery disease who sustained an inferior wall myocardial infarction shortly after taking zolmitriptan as abortive therapy for migraine headaches. A Medline search was performed to review all reported cases of myocardial infarction related to migraine therapy with zolmitriptan and related medications. Zolmitriptan may cause myocardial infarction (MI) even in the absence of significant coronary artery disease.
Pacheco-Coronado R, McMullan PW, Galbut BH, Galbut EJ, Snell J, Schaer GL, Kavinsky CJ. Myocardial infarction after taking zolmitriptan. Yale J Biol Med. 2005 May;78(3):147-50.
Weitere Infos finden sich hier.
Kommentare (0)
©migraeneinformation.de 2004 - 2018
|
|
|
|
|
Sonntag, 20. Mai 2018 |
|
|
|
 Das Wetter für
Frankfurt am Main |
|
|
| Migräne-Blog |
| Mai 2018 |
| Mo |
Di |
Mi |
Do |
Fr |
Sa |
So |
KW |
| |
01 |
02 |
03 |
04 |
05 |
06 |
18. |
| 07 |
08 |
09 |
10 |
11 |
12 |
13 |
19. |
| 14 |
15 |
16 |
17 |
18 |
19 |
20 |
20. |
| 21 |
22 |
23 |
24 |
25 |
26 |
27 |
21. |
| 28 |
29 |
30 |
31 |
|
|
|
22. |
| April |
|
|
|
|
|
